Comments for: Abuse-resistant OxyContin hits development snag

Abuse-resistant OxyContin hits development snag
WASHINGTON – An abuse-resistant form of the powerful but controversial painkiller OxyContin won’t be ready next year as its manufacturer had hoped. The widely prescribed narcotic painkiller is considered important therapy for many patients suffering long-term moderate to severe pain from cancer or other illnesses. Read More
      Read more

      You may also like

      By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.